Dr. Terris' clinical interests include urologic oncology, nerve-sparing radical prostatectomy, partial and complete kidney removal for cancer, testicular cancer surgery, adrenal cancer surgery, and intestinal bladder substitution (no external stoma) with radical cystectomy. Her research interests include prostate biopsy techniques, prostate cancer risk factors, bladder cancer risk factor, nutritional therapies for prostate cancer, and new imaging techniques for urologic cancers.
Areas of Expertise (8)
Media Appearances (4)
Bladder Cancer Awareness: MCG making strides to improves testing and outcomes
News Channel 6 tv
Bladder cancer is one of the most common cancers, impacting nearly 70,000 adults in the US each year. Dr. Martha Terris and Dr. Vinata Lokeshwar from the Medical College of Georgia are focused on the disease’s diagnosis and treatment, and share their expertise with viewers of The Means Report.
Looking for the “why” in bladder cancer deaths for African American patients
It has long been known that African Americans die at higher rates from bladder cancer than do European Americans. According to findings shared in the January publication of the American Cancer Society’s Cancer, differences in the way tumor cells in African American patients metabolize proteins and nutrients could be the key to unlocking why.
da Vinci XI robotic system offers new surgical options for patients
When it comes to performing complex surgery, even the best surgeon may need a helping hand, even if that hand is cold, metal and strong enough to hold the smallest of instruments. For that reason, Augusta University Health is introducing the da Vinci XI into the operating room.
Prostate cancer awareness
The Augusta Chronicle print
Prostate cancer may be the most common form of cancer in men and the third leading cause of cancer death in men, but women need to know they have an important role to play in the health of the men in their lives.
Klaassen Z1, Arora K2, Wilson SN3, King SA3, Madi R3, Neal DE Jr.3, Kurdyak P4, Kulkarni GS5, Lewis RW3, Terris MK3
Prostate cancer is the most common malignancy among males, accounting for 19% of cancers, and the third most common cancer-related cause of death. Suicide rates in the United States have increased among males over the last decade. Further, suicide rates are higher in oncology patients, including patients with prostate cancer, compared to the general population. The objective of this article is to review the current literature and address the relationship between prostate cancer, depression, erectile dysfunction, and suicidal ideation.
Sayyid Rashid K. , Simpson William G. , Lu Caroline , Terris Martha K. , Klaassen Zachary , and Madi Rabii
To report early operative outcomes and assess continence in 100 consecutive patients who underwent Retzius-sparing robotic-assisted laparoscopic radical prostatectomy (RALP).
Materials and Methods: This was a prospective, single-center, consecutive case series of 100 and 100 patients undergoing a Retzius-sparing and a conventional RALP, respectively, by a single surgeon between March 2015 and April 2017.
Robert J. Hamilton, Lionel L. Banez, William J. Aronson, Martha K. Terris, Elizabeth A. Platz, Christopher J. Kane, Joseph C. Presti, Christopher L. Amling, Stephen J. Freedland
Although controversial, evidence suggests statins may reduce the risk of advanced prostate cancer (PC), and recently statin use was associated with prostate-specific antigen (PSA) reductions among men without PC. The authors sought to examine the association between statin use and PSA recurrence after radical prostatectomy (RP).
Hodge KK, McNeal JE, Terris MK, Stamey TA
Random systematic ultrasound guided transrectal core biopsies of the prostate were compared to directed biopsies of specific hypoechoic defects in 136 men with abnormal prostates on digital rectal examination. Prostate cancer was diagnosed in 83 of 136 patients (62 per cent). In 80 of 83 individuals (94 per cent) the cancer was detected by random systematic biopsies alone. Of 57 men in whom random systematic and directed biopsies were obtained the results of biopsy agreed in 86 per cent, while in 9 per cent random systematic biopsies found cancers missed by directed biopsies and in 5 per cent directed biopsies diagnosed cancers missed by random systematic prostate biopsies. Ultrasound guided random systematic biopsy is simple and easily learned. When combined with additional directed biopsies of the rare hypoechoic areas not included in the pattern of systematic sampling, it provides a highly accurate means to diagnose prostate cancer, minimizing observer and sampling errors. This technique of prostate mapping with 6, 1.5 cm. cores provides valuable additional information on cancer volume, Gleason grade and the potential location of surgically positive margins, all without compromising the operation or the chance for a surgical cure.